Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura M. Spring
Observed names:
L Spring,
Laura M Spring
Institutions:
Harvard University,
Massachusetts General Hospital,
Mass General Brigham
Observed institutions:
Harvard University,
Vanderbilt University,
Massachusetts General Hospital,
Dana-Farber Cancer Institute,
Mass General Brigham,
European Institute of Oncology,
The University of Texas Southwestern Medical Center
show all 7
OpenAlex ID:
A5040089618
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer
2026
·
Paolo Tarantino
, Tianyu Li
, et al.
·
JAMA Oncology
·
2
PDF
Spatial/molecular heterogeneity and treatment response in HER2+ early breast cancer: Translational analyses from the DAPHNe trial
2026
·
Emily Chen
, Ilana Schlam
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Genomic biomarkers of ipatasertib response in patients with hormone receptor-positive metastatic breast cancer
2026
·
Maxwell R. Lloyd
, Zahra Bagheri
, et al.
·
npj Breast Cancer
PDF
A SIRT5-induced metabolic switch underlies chemoresistance and ATR checkpoint dependence in triple-negative breast cancer
2026
·
Zuen Ren
, Tiziano Bernasocchi
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract P1-15-01: Withdrawn
2019
·
O Metzger Filho
, M Janiszewska
, et al.
·
Cancer Research
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
